Control of BACE1 degradaton and APP processing by ubiquitin carboxyl-terminal hydrolase L1

Journal of Neurochemistry

Volumn 120, Issue 6, 2012, Pages 1129-1138

  Zhang, Mingming ^a   Deng, Yu ^a   Luo, Yawen ^a   Zhang, Shuting ^a   Zou, Haiyan ^a   Cai, Fang ^a   Wada, Keiji ^b   Song, Weihong ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

A ; Alzheimer's disease; BACE1; Deubiquitinating enzyme; Ubiquitin proteasome pathway; UCHL1

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; ESTERASE; UBIQUITIN THIOLESTERASE L1; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); ANTIBODY; ASPARTIC PROTEINASE; BACE1 PROTEIN, MOUSE; CYCLOHEXIMIDE; ENZYME INHIBITOR; INDOLE DERIVATIVE; LDN 57444; OXIME; PEPTIDE FRAGMENT; PROTEIN SYNTHESIS INHIBITOR; SECRETASE; UBIQUITIN THIOLESTERASE; UCHL1 PROTEIN, HUMAN;

ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; ENZYME DEGRADATION; ENZYME INHIBITION; GENE; GENE DISRUPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; UCHL1 GENE; ANIMAL; CELL LINE; DISEASE MODEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MUTATION; NEUROAXONAL DYSTROPHY; TIME;

MUS;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTIBODIES; ASPARTIC ACID ENDOPEPTIDASES; CELL LINE, TRANSFORMED; CYCLOHEXIMIDE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; INDOLES; MICE; MICE, NEUROLOGIC MUTANTS; MUTATION; NEUROAXONAL DYSTROPHIES; OXIMES; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SYNTHESIS INHIBITORS; TIME FACTORS; TRANSFECTION; UBIQUITIN THIOLESTERASE;

EID: 84857920499     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07644.x     Document Type: Article

References (62)

1. Amerik A. Y. and Hochstrasser M. (2004) Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta 1695, 189-207. (Pubitemid 39574973)
2. Bheda A., Yue W., Gullapalli A., Whitehurst C., Liu R., Pagano J. S. and Shackelford J. (2009) Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling. PLoS ONE 4, e5955.
3. Butterfield D. A., Gnjec A., Poon H. F., Castegna A., Pierce W. M., Klein J. B. and Martins R. N. (2006) Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment. J. Alzheimers Dis. 10, 391-397.
4. Cai H., Wang Y., McCarthy D., Wen H., Borchelt D. R., Price D. L. and Wong P. C. (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4, 233-234. (Pubitemid 32194867)
5. Castegna A., Aksenov M., Thongboonkerd V., Klein J. B., Pierce W. M., Booze R., Markesbery W. R. and Butterfield D. A. (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J. Neurochem. 82, 1524-1532.
6. Chen C. H., Zhou W., Liu S., Deng Y., Cai F., Tone M., Tone Y., Tong Y. and Song W. (2012) Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int. J. Neuropsychopharmacol. 15, 77-90.
7. Choi J., Levey A. I., Weintraub S. T., Rees H. D., Gearing M., Chin L. S. and Li L. (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 279, 13256-13264. (Pubitemid 38445905)
8. De Vrij F. M., Sluijs J. A., Gregori L., Fischer D. F., Hermens W. T., Goldgaber D., Verhaagen J., Van Leeuwen F. W. and Hol E. M. (2001) Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death. FASEB J. 15, 2680-2688. (Pubitemid 33131094)
9. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D. and Ward P. J. (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 1122-1124.
10. Fraser P. E., Levesque G. and Yu G. et al. (1998) Presenilin 1 is actively degraded by the 26S proteasome. Neurobiol. Aging 19, S19-S21. (Pubitemid 28178933)
11. Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890. (Pubitemid 14104991)
12. Gong B., Cao Z. and Zheng P. et al. (2006) Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775-788. (Pubitemid 44233627)
13. Goto A., Wang Y. L., Kabuta T., Setsuie R., Osaka H., Sawa A., Ishiura S. and Wada K. (2009) Proteomic and histochemical analysis of proteins involved in the dying-back-type of axonal degeneration in the gracile axonal dystrophy (gad) mouse. Neurochem. Int. 54, 330-338.
14. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y. C., Zaidi M. S. and Wisniewski H. M. (1986a) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261, 6084-6089. (Pubitemid 17207447)
15. Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M. and Binder L. I. (1986b) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913-4917.
16. Hadari T., Warms J. V., Rose I. A. and Hershko A. (1992) A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation. J. Biol. Chem. 267, 719-727.
17. He G., Qing H., Cai F., Kwok C., Xu H., Yu G., Bernstein A. and Song W. (2006) Ubiquitin-proteasome pathway mediates degradation of APH-1. J. Neurochem. 99, 1403-1412. (Pubitemid 44730094)
18. He G., Qing H., Tong Y., Cai F., Ishiura S. and Song W. (2007) Degradation of nicastrin involves both proteasome and lysosome. J. Neurochem. 101, 982-992. (Pubitemid 46683872)
19. Hershko A. and Ciechanover A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479. (Pubitemid 28411135)
20. Hussain I., Powell D. and Howlett D. R. et al. (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14, 419-427. (Pubitemid 30026585)
21. Ichihara N., Wu J., Chui D. H., Yamazaki K., Wakabayashi T. and Kikuchi T. (1995) Axonal degeneration promotes abnormal accumulation of amyloid beta-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res. 695, 173-178.
22. Jackson P. and Thompson R. J. (1981) The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis. J. Neurol. Sci. 49, 429-438. (Pubitemid 11184188)
23. Kay J. E. and Korner A. (1966) Effect of cycloheximide on protein and ribonucleic acid synthesis in cultured human lymphocytes. Biochem. J. 100, 815-822.
24. Keller J. N., Hanni K. B. and Markesbery W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439. (Pubitemid 30418211)
25. Kerridge D. (1958) The effect of actidione and other antifungal agents on nucleic acid and protein synthesis in Saccharomyces carlsbergensis. J. Gen. Microbiol. 19, 497-506.
26. Lam Y. A., DeMartino G. N., Pickart C. M. and Cohen R. E. (1997a) Specificity of the ubiquitin isopeptidase in the PA700 regulatory complex of 26 S proteasomes. J. Biol. Chem. 272, 28438-28446. (Pubitemid 27517791)
27. Lam Y. A., Xu W., DeMartino G. N. and Cohen R. E. (1997b) Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 385, 737-740. (Pubitemid 27098096)
28. Larsen C. N., Krantz B. A. and Wilkinson K. D. (1998) Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37, 3358-3368. (Pubitemid 28125563)
29. van Leeuwen F. W., de Kleijn D. P. and van den Hurk H. H. et al. (1998) Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279, 242-247.
30. Leroy E., Boyer R. and Auburger G. et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452.
31. Li Y., Zhou W., Tong Y., He G. and Song W. (2006) Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription. FASEB J. 20, 285-292. (Pubitemid 44933176)
32. Liu Y., Fallon L., Lashuel H. A., Liu Z. and Lansbury P. T., Jr (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111, 209-218. (Pubitemid 35292441)
33. Liu S., Bromley-Brits K., Xia K., Mittelholtz J., Wang R. and Song W. (2008) TMP21 degradation is mediated by the ubiquitin-proteasome pathway. Eur. J. Neurosci. 28, 1980-1988.
34. Lopez Salon M., Morelli L., Castano E. M., Soto E. F. and Pasquini J. M. (2000) Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302-310.
35. Luo Y., Bolon B. and Kahn S. et al. (2001) Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neurosci. 4, 231-232. (Pubitemid 32194866)
36. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L. and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249. (Pubitemid 15053619)
37. Mayer A. N. and Wilkinson K. D. (1989) Detection, resolution, and nomenclature of multiple ubiquitin carboxyl-terminal esterases from bovine calf thymus. Biochemistry 28, 166-172. (Pubitemid 19046733)
38. Momose Y., Murata M., Kobayashi K., Tachikawa M., Nakabayashi Y., Kanazawa I. and Toda T. (2002) Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann. Neurol. 51, 133-136. (Pubitemid 34027988)
39. Nijman S. M., Luna-Vargas M. P., Velds A., Brummelkamp T. R., Dirac A. M., Sixma T. K. and Bernards R. (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786. (Pubitemid 41721026)
40. Osaka H., Wang Y. L. and Takada K. et al. (2003) Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet. 12, 1945-1958. (Pubitemid 37038804)
41. Qing H., Zhou W., Christensen M. A., Sun X., Tong Y. and Song W. (2004) Degradation of BACE by the ubiquitin-proteasome pathway. FASEB J. 18, 1571-1573. (Pubitemid 39561636)
42. Roberds S. L., Anderson J. and Basi G. et al. (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10, 1317-1324. (Pubitemid 32600485)
43. Saigoh K., Wang Y. L. and Suh J. G. et al. (1999) Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23, 47-51. (Pubitemid 29418786)
44. Sakurai M., Sekiguchi M., Zushida K., Yamada K., Nagamine S., Kabuta T. and Wada K. (2008) Reduction in memory in passive avoidance learning, exploratory behaviour and synaptic plasticity in mice with a spontaneous deletion in the ubiquitin C-terminal hydrolase L1 gene. Eur. J. Neurosci. 27, 691-701. (Pubitemid 351239303)
45. Satoh J. and Kuroda Y. (2001) A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population. J. Neurol. Sci. 189, 113-117. (Pubitemid 32776657)
46. Schoenfeld A. R., Davidowitz E. J. and Burk R. D. (2000) Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Proc. Natl. Acad. Sci. USA 97, 8507-8512. (Pubitemid 30639703)
47. Setsuie R., Wang Y. L. and Mochizuki H. et al. (2007) Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem. Int. 50, 119-129. (Pubitemid 44879668)
48. Sinha S., Anderson J. P. and Barbour R. et al. (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540.
49. Sun X., He G. and Song W. (2006a) BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J. 20, 1369-1376. (Pubitemid 44943845)
50. Sun X., Tong Y., Qing H., Chen C. H. and Song W. (2006b) Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J. 20, 1361-1368. (Pubitemid 44943844)
51. Takami Y., Nakagami H. and Morishita R. et al. (2007) Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation. Arterioscler. Thromb. Vasc. Biol. 27, 2184-2190. (Pubitemid 350287248)
52. Thies W. and Bleiler L. (2011) 2011 Alzheimer's disease facts and figures. Alzheimers Dement. 7, 208-244.
53. Thrower J. S., Hoffman L., Rechsteiner M. and Pickart C. M. (2000) Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102. (Pubitemid 30009229)
54. Touitou R., Richardson J., Bose S., Nakanishi M., Rivett J. and Allday M. J. (2001) A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J. 20, 2367-2375. (Pubitemid 32452854)
55. Vassar R., Bennett B. D. and Babu-Khan S. et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
56. Wang R., Zhang M., Zhou W., Ly P. T., Cai F. and Song W. (2011) NF-kappaB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression. J. Neurochem. 116, 1160-1170.
57. Weissman A. M. (2001) Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2, 169-178.
58. Wilkinson K. D., Lee K. M., Deshpande S., Duerksen-Hughes P., Boss J. M. and Pohl J. (1989) The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246, 670-673. (Pubitemid 19283361)
59. Wilson P. O., Barber P. C., Hamid Q. A., Power B. F., Dhillon A. P., Rode J., Day I. N., Thompson R. J. and Polak J. M. (1988) The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br. J. Exp. Pathol. 69, 91-104.
60. Yamazaki K., Wakasugi N., Tomita T., Kikuchi T., Mukoyama M. and Ando K. (1988) Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse. Proc. Soc. Exp. Biol. Med. 187, 209-215. (Pubitemid 18077798)
61. Yan R., Bienkowski M. J. and Shuck M. E. et al. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537.
62. Zhang Z., Nadeau P., Song W., Donoviel D., Yuan M., Bernstein A. and Yankner B. A. (2000) Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. Nat. Cell Biol. 2, 463-465.